Business Description
Atrion Corp
NAICS : 339112
SIC : 3841
ISIN : US0499041053
Share Class Description:
ATRI: Ordinary SharesDescription
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.39 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Interest Coverage | 151.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 28.43 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.2 | |||||
| 3-Year EBITDA Growth Rate | -6 | |||||
| 3-Year EPS without NRI Growth Rate | -12 | |||||
| 3-Year Book Growth Rate | 1.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.97 | |||||
| 9-Day RSI | 57.59 | |||||
| 14-Day RSI | 54.69 | |||||
| 6-1 Month Momentum % | 27.28 | |||||
| 12-1 Month Momentum % | -33.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.09 | |||||
| Quick Ratio | 2.57 | |||||
| Cash Ratio | 0.5 | |||||
| Days Inventory | 263.77 | |||||
| Days Sales Outstanding | 48.88 | |||||
| Days Payable | 43.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.19 | |||||
| Dividend Payout Ratio | 0.76 | |||||
| 3-Year Dividend Growth Rate | 9.6 | |||||
| Forward Dividend Yield % | 2.19 | |||||
| 5-Year Yield-on-Cost % | 3.77 | |||||
| 3-Year Average Share Buyback Ratio | 1.2 | |||||
| Shareholder Yield % | 2.3 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.85 | |||||
| Operating Margin % | 13.34 | |||||
| Net Margin % | 11.46 | |||||
| FCF Margin % | -1.37 | |||||
| ROE % | 8.07 | |||||
| ROA % | 7.36 | |||||
| ROIC % | 8.3 | |||||
| ROC (Joel Greenblatt) % | 10.74 | |||||
| ROCE % | 9.28 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.2 | |||||
| PE Ratio without NRI | 34.86 | |||||
| Shiller PE Ratio | 19.9 | |||||
| PS Ratio | 4.13 | |||||
| PB Ratio | 2.89 | |||||
| Price-to-Tangible-Book | 3.03 | |||||
| Price-to-Operating-Cash-Flow | 35.14 | |||||
| EV-to-EBIT | 32.46 | |||||
| EV-to-EBITDA | 19.6 | |||||
| EV-to-Revenue | 4.41 | |||||
| EV-to-FCF | -322.74 | |||||
| Price-to-Projected-FCF | 2.13 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Graham-Number | 2.17 | |||||
| Price-to-Net-Current-Asset-Value | 7.25 | |||||
| Earnings Yield (Greenblatt) % | 3.08 | |||||
| FCF Yield % | -0.33 | |||||
| Forward Rate of Return (Yacktman) % | 0.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ATRI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atrion Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 169.326 | ||
| EPS (TTM) ($) | 11.02 | ||
| Beta | 1.07 | ||
| Volatility % | 52.9 | ||
| 14-Day RSI | 54.69 | ||
| 14-Day ATR ($) | 21.091522 | ||
| 20-Day SMA ($) | 412.7475 | ||
| 12-1 Month Momentum % | -33.64 | ||
| 52-Week Range ($) | 274.98 - 630.98 | ||
| Shares Outstanding (Mil) | 1.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Atrion Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Atrion Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Atrion Corp Frequently Asked Questions
What is Atrion Corp(ATRI)'s stock price today?
The current price of ATRI is $398.97. The 52 week high of ATRI is $630.98 and 52 week low is $274.98.
When is next earnings date of Atrion Corp(ATRI)?
The next earnings date of Atrion Corp(ATRI) is 2024-05-08 Est..
Does Atrion Corp(ATRI) pay dividends? If so, how much?
The Dividend Yield %  of Atrion Corp(ATRI) is 2.19% (As of Today), Highest Dividend Payout Ratio of Atrion Corp(ATRI) was 0.76. The lowest was 0.2. And the median was 0.28. The  Forward Dividend Yield % of Atrion Corp(ATRI) is 2.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers